ResultsIQ › Latest results › Meghmani Organics Limited
Meghmani Organics Limited Q2 FY27 results deck summary
NSE: MOL · BSE: 543331
Results deck of 4 Nov 2026, summarised by AI from the filing.
Meghmani Organics Q2 FY27 standalone revenue rose 18% to ₹658.2 cr, but EBITDA stayed flat at ₹70.9 cr with margin at 10.8%.
Key takeaways
- Q2 revenue Standalone revenue from operations rose 18% YoY to ₹658.2 cr, while EBITDA stayed flat at ₹70.9 cr and margin fell to 10.8%.
- Margin target The capex programme is targeted to lift blended EBITDA margin to ~14-15%, with no period stated.
- TiO2 duty The Ministry of Finance reimposed anti-dumping duty on TiO2 imports from China for five years on 24 October 2026, supporting the new TiO2 business.
- Cost pressure EBITDA margin was under pressure from elevated input and logistics costs while realisation stayed broadly flat.
Meghmani Organics Limited Q2 FY27 results
As filed: Revenue ₹667 cr (+16% year on year), EBITDA ₹73.1 cr (+41% year on year), PAT ₹33.9 cr (+182% year on year), EBITDA margin 11.0% (+195 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹543 cr (−12% year on year), EBITDA ₹97.9 cr (+48% year on year), PAT ₹48.2 cr (+271% year on year), EBITDA margin 18.0% (+729 bps). Score 36 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA growth was below it. EBITDA margin rose 729 bps year on year. Share price after the results: +8.2% in 30 days (Nifty 500: +0.8%).
- Q4 FY26: Revenue ₹474 cr (−14% year on year), EBITDA ₹19.7 cr (−70% year on year), PAT ₹8.0 cr (−60% year on year), EBITDA margin 4.2% (−760 bps). Score 11 of 100, Below trend. Revenue and EBITDA growth were well below the company's own trend. EBITDA margin fell 760 bps year on year. Other income 521% of PBT. Tax rate -12%. Revenue fell 7% from last quarter. Share price after the results: −8.6% in 29 days (Nifty 500: −0.1%).
- Q3 FY26: Revenue ₹509 cr (−11% year on year), EBITDA ₹37.7 cr (−8% year on year), PAT −₹3.5 cr, EBITDA margin 7.4% (+21 bps). Score 23 of 100, Below trend. Revenue and EBITDA growth were below the company's own trend. EBITDA margin rose 21 bps year on year. Other income 329% of PBT. Tax rate 178%. Revenue fell 12% from last quarter. Share price after the results: −9.3% in 30 days (Nifty 500: −1.1%).
- Q2 FY26: Revenue ₹577 cr (+6% year on year), EBITDA ₹52.0 cr (+73% year on year), PAT ₹12.0 cr, EBITDA margin 9.0% (+350 bps). Score 35 of 100, Below trend. Revenue and EBITDA growth were in line with the company's own trend. EBITDA margin rose 350 bps year on year. Other income 108% of PBT. Tax rate 54%. Revenue fell 6% from last quarter. Share price after the results: −15.2% in 30 days (Nifty 500: 0.0%).
- Q1 FY26: Revenue ₹614 cr (+48% year on year), EBITDA ₹66.0 cr (+300% year on year), PAT ₹13.0 cr, EBITDA margin 10.8% (+930 bps). Score 59 of 100, In line with trend. Revenue and EBITDA growth were above the company's own trend. EBITDA margin rose 930 bps year on year. Other income 71% of PBT. Tax rate 46%. Profit fell 35% from last quarter. Share price after the results: −18.3% in 30 days (Nifty 500: −2.4%).
- Q4 FY25: Revenue ₹553 cr (+35% year on year), EBITDA ₹65.0 cr (+300% year on year), PAT ₹20.0 cr, EBITDA margin 11.8% (+1,000 bps). Score 56 of 100, In line with trend. Revenue growth was above the company's own trend. EBITDA margin rose 1000 bps year on year. Other income 45% of PBT. Tax rate 35%. Share price after the results: +29.6% in 30 days (Nifty 500: +7.6%).
- Q3 FY25: Revenue ₹569 cr (+62% year on year), EBITDA ₹41.0 cr, PAT −₹4.0 cr, EBITDA margin 7.2% (+948 bps). Score 45 of 100, In line with trend. Revenue growth was well above the company's own trend. EBITDA margin rose 948 bps year on year. Other income 129% of PBT. Tax rate 171%.
Past price moves after results do not indicate future moves. Not a recommendation.
Meghmani Organics Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Earnings call (5 Nov 2026), Results deck (4 Nov 2026), Results press release (4 Nov 2026)
- Q1 FY27: Earnings call (30 Jul 2026), Results deck (29 Jul 2026)
- Q4 FY26: Earnings call (16 May 2026), Results deck (14 May 2026), Results press release (14 May 2026)
- Q3 FY26: Earnings call (2 Feb 2026), Results deck (31 Jan 2026), Results press release (31 Jan 2026)
- Q2 FY26: Earnings call (12 Nov 2025), Results deck (8 Nov 2025), Results press release (8 Nov 2025)
- Q1 FY26: Earnings call (31 Jul 2025), Results deck (30 Jul 2025), Results press release (30 Jul 2025)
- Q4 FY25: Earnings call (12 May 2025), Results deck (10 May 2025), Results press release (10 May 2025)
- Other events: Strategy deck (6 Apr 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.